Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $8.0 million.

  • Fresenius Medical Care AG's Receivables - Other fell 9440.9% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 9440.9%. This contributed to the annual value of $43.7 million for FY2024, which is 8253.91% down from last year.
  • Fresenius Medical Care AG's Receivables - Other amounted to $8.0 million in Q3 2025, which was down 9440.9% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Receivables - Other ranged from a high of $250.5 million in Q4 2023 and a low of -$34.7 million during Q3 2021
  • For the 5-year period, Fresenius Medical Care AG's Receivables - Other averaged around $68.9 million, with its median value being $43.7 million (2024).
  • Its Receivables - Other has fluctuated over the past 5 years, first tumbled by 31407.67% in 2022, then soared by 36826.01% in 2023.
  • Fresenius Medical Care AG's Receivables - Other (Quarter) stood at $185.7 million in 2021, then grew by 9.06% to $202.6 million in 2022, then increased by 23.68% to $250.5 million in 2023, then crashed by 82.54% to $43.7 million in 2024, then crashed by 81.81% to $8.0 million in 2025.
  • Its Receivables - Other stands at $8.0 million for Q3 2025, versus $4.0 million for Q2 2025 and $14.5 million for Q1 2025.